SML3299
S-Ketorolac
≥98% (HPLC)
别名:
(-)-Ketorolac, (1S)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, (S)-Ketorolac
质量水平
方案
≥98% (HPLC)
表单
powder
旋光性
[α]/D -165 to -185°, c = 0.5 in methanol
颜色
white to beige
溶解性
DMSO: 2 mg/mL, clear
储存温度
2-8°C
SMILES字符串
[n]21c(ccc2C(=O)c3ccccc3)[C@H](CC1)C(=O)O
InChI
1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)/t11-/m0/s1
InChI key
OZWKMVRBQXNZKK-NSHDSACASA-N
相关类别
生化/生理作用
S-Ketorolac is an active enantiomer of nonsteroidal anti-inflammatory drug Ketorolac. S-Ketorolac is a selective and potent cyclooxygenase 1/2 (COX-1/2) inhibitor which exhibits anti-inflammatory activities. It is significantly more potent than non-selective COX inhibitors indomethacin or diclofenac.
selective and potent COX-1/2 inhibitor
警示用语：
Danger
危险声明
危险分类
Acute Tox. 3 Oral
储存分类代码
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
此项目有
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
Pyry A Välitalo et al.
British journal of clinical pharmacology, 83(9), 1966-1975 (2017-04-22)
Although ketorolac analgesia is linked only to the S-enantiomer, there is limited information on the stereo-selective pharmacokinetics of this agent. We studied the stereo-selective pharmacokinetics of ketorolac in a pooled dataset of two studies, with women at delivery and 4-5 months
M F Jett et al.
The Journal of pharmacology and experimental therapeutics, 288(3), 1288-1297 (1999-02-23)
The marked analgesic efficacy of ketorolac in humans, relative to other nonsteroidal anti-inflammatory drugs (NSAIDs), has lead to speculation as to whether additional non-NSAID mechanism(s) contribute to its analgesic actions. To evaluate this possibility, we characterized (R,S)-ketorolac's pharmacological properties in
Laurie G Hudson et al.
Cancers, 11(8) (2019-07-28)
Cytoreductive surgery and chemotherapy are cornerstones of ovarian cancer treatment, yet disease recurrence remains a significant clinical issue. Surgery can release cancer cells into the circulation, suppress anti-tumor immunity, and induce inflammatory responses that support the growth of residual disease.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持